Search Results - "Razavian, Mona"

Antiplatelet Therapy to Prevent Hemodialysis Vascular Access Failure: Systematic Review and Meta-analysis by Palmer, Suetonia C., MBChB, PhD, Di Micco, Lucia, MD, Razavian, Mona, MBBS, Craig, Jonathan C., MBChB, DCH, MM, PhD, Ravani, Pietro, MD, PhD, Perkovic, Vlado, MBBS, PhD, Tognoni, Gianni, MD, Graziano, Giusi, MSc, Jardine, Meg, MBBS, PhD, Pellegrini, Fabio, MSc, Nicolucci, Antonio, MD, Webster, Angela, MBBS, PhD, Strippoli, Giovanni F.M., MD, PhD, MPH, MM

“…Background Hemodialysis vascular access failure occurs often and increases morbidity for people on hemodialysis therapy. Antiplatelet agents may prevent…”
Get full text

Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial by Lv, Jicheng, Wong, Muh Geot, Hladunewich, Michelle A, Jha, Vivekanand, Hooi, Lai Seong, Monaghan, Helen, Zhao, Minghui, Barbour, Sean, Jardine, Meg J, Reich, Heather N, Cattran, Daniel, Glassock, Richard, Levin, Adeera, Wheeler, David C, Woodward, Mark, Billot, Laurent, Stepien, Sandrine, Rogers, Kris, Chan, Tak Mao, Liu, Zhi-Hong, Johnson, David W, Cass, Alan, Feehally, John, Floege, Jürgen, Remuzzi, Giuseppe, Wu, Yangfeng, Agarwal, Rajiv, Zhang, Hong, Perkovic, Vlado

“…IMPORTANCE: The effect of glucocorticoids on major kidney outcomes and adverse events in IgA nephropathy has been uncertain. OBJECTIVE: To evaluate the…”
Get full text

Antioxidants for chronic kidney disease by Jun, Min, Venkataraman, Vinod, Razavian, Mona, Cooper, Bruce, Zoungas, Sophia, Ninomiya, Toshiharu, Webster, Angela C, Perkovic, Vlado

“…Chronic kidney disease (CKD) is a significant risk factor for premature cardiovascular disease and death. Increased oxidative stress in people with CKD has…”
Get more information

Antiplatelet agents for chronic kidney disease by Natale, Patrizia, Palmer, Suetonia C, Saglimbene, Valeria M, Ruospo, Marinella, Razavian, Mona, Craig, Jonathan C, Jardine, Meg J, Webster, Angela C, Strippoli, Giovanni Fm

“…Antiplatelet agents are widely used to prevent cardiovascular events. The risks and benefits of antiplatelet agents may be different in people with chronic…”
Get more information

Effects of Antiplatelet Therapy on Mortality and Cardiovascular and Bleeding Outcomes in Persons With Chronic Kidney Disease: A Systematic Review and Meta-analysis by PALMER, Suetonia C, DI MICCO, Lucia, WEBSTER, Angela, NICOLUCCI, Antonio, ZOUNGAS, Sophia, STRIPPOLI, Giovanni F. M, RAZAVIAN, Mona, CRAIG, Jonathan C, PERKOVIC, Vlado, PELLEGRINI, Fabio, COPETTI, Massimiliano, GRAZIANO, Giusi, TOGNONI, Gianni, JARDINE, Meg

“…Antiplatelet agents are used to prevent cardiovascular events; however, treatment effects may differ in persons with chronic kidney disease (CKD) because…”
Get full text

A Case of Spontaneous Bilateral Renal Artery Dissection Following Robotic Surgery by Macneil, James W.H., Razavian, Mona, Stephen, Michael S., Lau, Howard M.

Get full text

Cardiovascular risk management in chronic kidney disease in general practice (the AusHEART study) by Razavian, Mona, Heeley, Emma L, Perkovic, Vlado, Zoungas, Sophia, Weekes, Andrew, Patel, Anushka A, Anderson, Craig S, Chalmers, John P, Cass, Alan

“…Chronic kidney disease (CKD) is common and increasing in prevalence. Adverse outcomes of CKD can be prevented through early detection and treatment. There is…”
Get full text

Clinical Adjudication of Hemodialysis Catheter-Related Bloodstream Infections: Findings from the REDUCCTION Trial by Catiwa, Jayson, Gallagher, Martin, Talbot, Benjamin, Kerr, Peter G, Semple, David J, Roberts, Matthew A, Polkinghorne, Kevan R, Gray, Nicholas A, Talaulikar, Girish, Cass, Alan, Kotwal, Sradha

“…Key Points The inter-rater reliability of reporting hemodialysis catheter-related infectious events between site investigators and trial adjudicators in…”
Get full text

Effect of a Vascular Access Surveillance Program on Service Provision and Access Thrombosis by Jiang, Simon, Stewart, Glenn, Barnes, Elizabeth, Jardine, Meg, Razavian, Mona, Gallagher, Martin

“…Establishing and maintaining hemodialysis access are major challenges in dialysis patient care. The impact of implementing guideline recommendations around…”
Get full text

Antiplatelet agents for chronic kidney disease by Palmer, Suetonia C, Di Micco, Lucia, Razavian, Mona, Craig, Jonathan C, Perkovic, Vlado, Pellegrini, Fabio, Jardine, Meg J, Webster, Angela C, Zoungas, Sophia, Strippoli, Giovanni F M

“…Antiplatelet agents are widely used to prevent cardiovascular events. The risks and benefits of antiplatelet treatment may be different in people with chronic…”
Get more information

Cardiovascular risk management in chronic kidney disease in general practice (the AusHEART study) by RAZAVIAN, Mona, HEELEY, Emma L, PERKOVIC, Vlado, ZOUNGAS, Sophia, WEEKES, Andrew, PATEL, Anushka A, ANDERSON, Craig S, CHALMERS, John P, CASS, Alan

Get full text